Clinical trial
A Post Market Clinical Study Evaluating the Safety, Device Performance and Possible Emergent Risks of Celotres in the Improvement of Wound Healing and the Resulting Scar Consequences Following Suturing of a Wound
NCT01706848 is registered in ClinicalTrials.gov with Halscion, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post Market Clinical Study Evaluating the Safety, Device Performance and Possible Emergent Risks of Celotres in the Improvement of Wound Healing and the Resulting Scar Consequences Following Suturing of a Wound
- Lead sponsor
- Halscion, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- May 31, 2014
- Enrollment
- 60 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
scar